1031 related articles for article (PubMed ID: 16507053)
1. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
Carson CC
BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
[TBL] [Abstract][Full Text] [Related]
2. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
Lowe FC
BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
4. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
Yassin A; Saad F; Hoesl CE; Traish AM; Hammadeh M; Shabsigh R
Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236
[TBL] [Abstract][Full Text] [Related]
5. Impact of medical treatments for benign prostatic hyperplasia on sexual function.
Giuliano F
BJU Int; 2006 Apr; 97 Suppl 2():34-8; discussion 44-5. PubMed ID: 16507052
[TBL] [Abstract][Full Text] [Related]
6. Lower urinary tract symptoms and sexual dysfunction: a common approach.
Giuliano F
BJU Int; 2008 Mar; 101 Suppl 3():22-6. PubMed ID: 18307682
[TBL] [Abstract][Full Text] [Related]
7. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
8. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Rosen RC; Giuliano F; Carson CC
Eur Urol; 2005 Jun; 47(6):824-37. PubMed ID: 15925080
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia.
Wang C
Curr Opin Urol; 2010 Jan; 20(1):49-54. PubMed ID: 19887943
[TBL] [Abstract][Full Text] [Related]
10. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Kaplan SA; Gonzalez RR; Te AE
Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
[TBL] [Abstract][Full Text] [Related]
11. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
Rosen RC
Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.
Wong P; Lawrentschuk N; Bolton DM
Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.
Gales BJ; Gales MA
Ann Pharmacother; 2008 Jan; 42(1):111-5. PubMed ID: 18094344
[TBL] [Abstract][Full Text] [Related]
14. Comorbid LUTS and erectile dysfunction: optimizing their management.
Kaminetsky J
Curr Med Res Opin; 2006 Dec; 22(12):2497-506. PubMed ID: 17265598
[TBL] [Abstract][Full Text] [Related]
15. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
16. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
Seftel A; Rosen R; Kuritzky L
Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of the simultaneous administration of udenafil and an alpha-blocker in men with erectile dysfunction concomitant with BPH/LUTS.
Chung BH; Lee JY; Lee SH; Yoo SJ; Lee SW; Oh CY
Int J Impot Res; 2009; 21(2):122-8. PubMed ID: 19194451
[TBL] [Abstract][Full Text] [Related]
18. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction.
Broderick GA; Brock GB; Roehrborn CG; Watts SD; Elion-Mboussa A; Viktrup L
Urology; 2010 Jun; 75(6):1452-8. PubMed ID: 20163842
[TBL] [Abstract][Full Text] [Related]
19. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
[TBL] [Abstract][Full Text] [Related]
20. Common approach to managing lower urinary tract symptoms and erectile dysfunction.
Taylor JM; Desouza R; Wang R
Asian J Androl; 2008 Jan; 10(1):45-53. PubMed ID: 18087643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]